Abstract
Abstract
Background
Kidney failure has been associated with decreased physical capacity, although evidence regarding the physical performance of individuals with earlier stages of chronic kidney disease (CKD) remains limited.
Methods
Cross-sectional data were derived from the prospective, population-based Maastricht Study. Multivariate linear regression models were fitted to assess the association of estimated glomerular filtration rate (eGFR) and albuminuria categories with physical performance test outcomes.
Results
Overall, 7396 participants were included. Compared to eGFR 60–90 ml/min/1.73 m2, values < 60 ml/min/1.73 m2 were associated with significantly shorter 6-min walk distance (β: − 13.04 m, 95% confidence intervals-CI − 19.95; − 6.13), worse timed chair rise stand test time (β: 0.91 s, 95% CI 0.36; 1.47), lower maximal grip (β: − 0.83 kg, 95% CI − 1.50; − 0.15) and elbow flexion (β: − 3.64 Nm, 95% CI − 7.11; − 0.16) strength. Additionally, eGFR > 90 ml/min/1.73 m2 was linked to significantly shorter 6-min walk distance (β: − 6.13 m, 95% CI − 9.44; − 2.82). Urinary albumin excretion > 30 mg/24 h was associated with shorter 6-min walk distance (β: − 12.48 m, 95% CI − 18.28; − 6.68), worse timed chair rise stand test time (β: 0.51 s, 95% CI 0.11; 1.06), lower maximal grip (β: − 1.34 kg, 95% CI − 1.91; − 0.76) and elbow flexion strength (β: − 3.31 Nm, 95% CI − 5.80; − 0.82).
Conclusions
Reduced eGFR and higher albuminuria levels were associated with worse physical performance, especially shorter 6-min walk distance and lower muscle strength. The relationship between eGFR and physical function was non-linear, with also high eGFR values being associated with worse performance, especially in the six-minute walk test.
Graphical abstract
Funder
European Regional Development Fund
Province of Limburg
Dutch Ministry of Economic Affairs
Stichting De Weijerhorst
Pearl String Initiative Diabetes
School for Cardiovascular Diseases
School for Public Health and Primary Care
School for Nutrition and Translational Research in Metabolism
Stichting Annadal
), Health Foundation Limburg
Janssen-Cilag B.V.
Novo Nordisk Farma B.V.
Sanofi-Aventis Netherlands B.V.
Medtronic
University of Athens
Publisher
Springer Science and Business Media LLC